Savara (SVRA) Stock Forecast, Price Target & Predictions
SVRA Stock Forecast
Savara (SVRA) stock forecast, based on 11 Wall Street analysts, predicts a 12-month average price target of $9.40, with a high of $11.00 and a low of $5.00. This represents a 62.63% increase from the last price of $5.78.
SVRA Stock Rating
Savara stock's rating consensus is Buy, based on 11 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 9 Buy (81.82%), 2 Hold (18.18%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).
Buy
SVRA Price Target Upside V Benchmarks
| Type | Name | Upside |
|---|---|---|
| Stock | Savara | 62.63% |
| Sector | Healthcare Stocks | 15.45% |
| Industry | Biotech Stocks | 41.48% |
Price Target Trends
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | 2 | 5 |
| Avg Price Target | - | $10.00 | $9.40 |
| Last Closing Price | $5.78 | $5.78 | $5.78 |
| Upside/Downside | - | 73.01% | 62.63% |
Ratings Trends
| Date | Strong Buy | Buy | Hold | Sell | Strong Sell | Total |
|---|---|---|---|---|---|---|
| Jan, 26 | 2 | 6 | - | - | - | 8 |
| Dec, 25 | 2 | 6 | - | - | - | 8 |
| Nov, 25 | 3 | 5 | - | - | - | 8 |
| Oct, 25 | 3 | 4 | - | - | - | 7 |
| Sep, 25 | 3 | 4 | - | - | - | 7 |
Analyst Price Target Forecasts
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Dec 23, 2025 | Oppenheimer | $10.00 | $6.47 | 54.56% | 73.01% | |
| Oct 23, 2025 | JMP Securities | $11.00 | $4.24 | 159.43% | 90.31% | |
| Sep 09, 2025 | Guggenheim | $11.00 | $3.82 | 187.96% | 90.31% | |
| Aug 15, 2025 | Andrew Fein | H.C. Wainwright | $5.00 | $3.09 | 61.81% | -13.49% |
| Aug 13, 2024 | Jonathan Wolleben | JMP Securities | $4.50 | $2.04 | 120.59% | -22.15% |
| Jun 27, 2024 | Vamil Divan | Guggenheim | $5.00 | $1.92 | 160.42% | -13.49% |
| Jun 27, 2024 | Andrew Fein | H.C. Wainwright | $5.00 | $1.92 | 160.42% | -13.49% |
| Jun 27, 2024 | Jonathan Wolleben | JMP Securities | $5.00 | $1.98 | 152.53% | -13.49% |
| May 21, 2024 | Francois Brisebois | Oppenheimer | $5.50 | $2.16 | 154.63% | -4.84% |
Analyst Rating Forecasts
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Dec 23, 2025 | Guggenheim | Buy | Buy | hold |
| Dec 23, 2025 | H.C. Wainwright | Buy | Buy | hold |
| Oct 23, 2025 | Citigroup | Outperform | Outperform | hold |
| Sep 09, 2025 | Guggenheim | Buy | Buy | hold |
| Sep 08, 2025 | Oppenheimer | Outperform | Outperform | hold |
| Sep 03, 2025 | H.C. Wainwright | Buy | Buy | hold |
| Aug 15, 2025 | H.C. Wainwright | Neutral | Buy | upgrade |
| May 29, 2025 | H.C. Wainwright | Buy | Neutral | downgrade |
| May 28, 2025 | Guggenheim | Buy | Buy | hold |
| Oct 03, 2024 | Piper Sandler | Overweight | Overweight | hold |
Financial Forecast
EPS Forecast
Annual
| Dec 23 | Dec 24 | Dec 25 | Dec 26 | Dec 27 | Dec 28 | |
|---|---|---|---|---|---|---|
| Reported | $-0.33 | $-0.48 | - | - | - | - |
| Avg Forecast | $-0.35 | $-0.46 | $-0.49 | $-0.25 | $-0.01 | $0.21 |
| High Forecast | $-0.34 | $-0.45 | $-0.46 | $-0.04 | $0.18 | $0.21 |
| Low Forecast | $-0.36 | $-0.47 | $-0.54 | $-0.44 | $-0.16 | $0.21 |
| Surprise % | -5.71% | 4.35% | - | - | - | - |
Revenue Forecast
Annual
| Dec 23 | Dec 24 | Dec 25 | Dec 26 | Dec 27 | Dec 28 | |
|---|---|---|---|---|---|---|
| Reported | - | - | - | - | - | - |
| Avg Forecast | - | - | $1.39M | $50.60M | $119.56M | $185.09M |
| High Forecast | - | - | $1.39M | $50.60M | $122.02M | $185.09M |
| Low Forecast | - | - | $1.39M | $50.60M | $117.11M | $185.09M |
| Surprise % | - | - | - | - | - | - |
Net Income Forecast
Annual
| Dec 23 | Dec 24 | Dec 25 | Dec 26 | Dec 27 | Dec 28 | |
|---|---|---|---|---|---|---|
| Reported | $-54.70M | $-95.88M | - | - | - | - |
| Avg Forecast | $-58.10M | $-76.20M | $-83.07M | $-58.35M | $-1.07M | $35.11M |
| High Forecast | $-56.44M | $-74.51M | $-76.68M | $-6.61M | $29.94M | $35.11M |
| Low Forecast | $-59.76M | $-77.89M | $-89.46M | $-72.69M | $-25.81M | $35.11M |
| Surprise % | -5.85% | 25.83% | - | - | - | - |